Literature DB >> 7031224

Pancreatic endocrine responses to exogenous neurotensin in the conscious calf.

A M Blackburn, S R Bloom, A V Edwards.   

Abstract

1. Responses to neurotensin have been investigated in conscious calves 2-5 weeks after birth given continuous I.V. infusions of the peptide for 15 min (5 pmol. kg-1 . min-1). 2. In control calves the concentration of the peptide in the arterial plasma had risen by 160 +/- 10 pmol/l at the end of the infusion,. after which it fell exponentially (t1/2: 1.4 min). 3. This dose of neurotensin produced no significant change in mean heart rate, aortic blood pressure, plasma gastrin or glucose concentration. 4. It was found that neurotensin could produce a pronounced rise in the concentration of both insulin and pancreatic polypeptide (PP) in the arterial plasma, together with a much smaller rise in pancreatic glucagon concentration. 5. Each of these three pancreatic endocrine responses was found to be glucose-sensitive within the range ca. 5.0-9.0 mmol/l. Hyperglycaemia potentiated insulin release and inhibited release of PP and glucagon. 6. The results are discussed in relation to the findings of other workers in other species.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7031224      PMCID: PMC1249412          DOI: 10.1113/jphysiol.1981.sp013686

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  16 in total

1.  The release of pancreatic glucagon and inhibition of insulin in response to stimulation of the sympathetic innervation.

Authors:  S R Bloom; A V Edwards
Journal:  J Physiol       Date:  1975-12       Impact factor: 5.182

2.  Current problems in the measurement of gastrin release. A reproducible measure of physiological gastrin release.

Authors:  R C Russel; S R Bloom; L P Fielding; M G Bryant
Journal:  Postgrad Med J       Date:  1976-10       Impact factor: 2.401

3.  Structure-function and structure-immunoreactivity relationships of the glucagon molecule and related synthetic peptides.

Authors:  R Assan; N Slusher
Journal:  Diabetes       Date:  1972-08       Impact factor: 9.461

4.  The isolation of a new hypotensive peptide, neurotensin, from bovine hypothalami.

Authors:  R Carraway; S E Leeman
Journal:  J Biol Chem       Date:  1973-10-10       Impact factor: 5.157

5.  A sensitive, precise radioimmunoassay of serum insulin relying on charcoal separation of bound and free hormone moieties.

Authors:  J D Albano; R P Ekins; G Maritz; R C Turner
Journal:  Acta Endocrinol (Copenh)       Date:  1972-07

6.  Hyperglycemic effect of neurotensin, a hypothalamic peptide.

Authors:  R E Carraway; L M Demers; S E Leeman
Journal:  Endocrinology       Date:  1976-12       Impact factor: 4.736

7.  Effects of neurotensin and substance P on plasma insulin, glucagon and glucose levels.

Authors:  M Brown; W Vale
Journal:  Endocrinology       Date:  1976-03       Impact factor: 4.736

8.  The glycogenolytic response to stimulation of the splanchnic nerves in adrenalectomized calves.

Authors:  A V Edwards; M Silver
Journal:  J Physiol       Date:  1970-11       Impact factor: 5.182

9.  The effect of ingestion of amino acids, glucose and fat on circulating neurotensin-like immunoreactivity (NTLI) in man.

Authors:  S Rosell; A Rökaeus
Journal:  Acta Physiol Scand       Date:  1979-11

10.  The role of the sympathetic innervation in the control of plasma glucagon concentration in the calf.

Authors:  S R Bloom; A V Edwards; N J Vaughan
Journal:  J Physiol       Date:  1973-09       Impact factor: 5.182

View more
  6 in total

1.  Effects of certain metabolites on pancreatic endocrine responses to gastrin-releasing peptide in conscious calves.

Authors:  S R Bloom; A V Edwards; M A Ghatei
Journal:  J Physiol       Date:  1984-01       Impact factor: 5.182

2.  Pancreatic endocrine responses to stimulation of the peripheral ends of the vagus nerves in conscious calves.

Authors:  S R Bloom; A V Edwards
Journal:  J Physiol       Date:  1981-06       Impact factor: 5.182

3.  Pancreatic endocrine responses to physiological changes in plasma neurotensin concentration in the calf.

Authors:  A M Blackburn; S R Bloom; A V Edwards
Journal:  J Physiol       Date:  1981-09       Impact factor: 5.182

4.  Developmental changes in pancreatic endocrine function in the young calf.

Authors:  S R Bloom; A V Edwards
Journal:  J Physiol       Date:  1981-05       Impact factor: 5.182

5.  Neurotensin differentially regulates bile acid metabolism and intestinal FXR-bile acid transporter axis in response to nutrient abundance.

Authors:  Jing Li; Jun Song; Baoxiang Yan; Heidi L Weiss; L Todd Weiss; Tianyan Gao; B Mark Evers
Journal:  FASEB J       Date:  2021-05       Impact factor: 5.834

Review 6.  New Insights in the Control of Fat Homeostasis: The Role of Neurotensin.

Authors:  Ilaria Barchetta; Marco Giorgio Baroni; Olle Melander; Maria Gisella Cavallo
Journal:  Int J Mol Sci       Date:  2022-02-17       Impact factor: 6.208

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.